April 4, 2016 – TARRYTOWN, N.Y., – PGI Drug Discovery LLC (PsychoGenics), today announced that a compound identified through its drug discovery collaboration with Sunovion Pharmaceuticals Inc. (Sunovion) has achieved a milestone.
April 4, 2016 – TARRYTOWN, N.Y., – PGI Drug Discovery LLC (PsychoGenics), today announced that a compound identified through its drug discovery collaboration with Sunovion Pharmaceuticals Inc. (Sunovion) has achieved a milestone.
